|
|
Volumn 56, Issue 23-24, 1995, Pages 1941-1947
|
|
Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist
|
|
Author keywords
cAMP; cannabinoid receptor; cGMP; receptor antagonist
|
|
Indexed keywords
2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE;
4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL;
ANANDAMIDE;
CANNABINOID RECEPTOR;
CANNABINOID RECEPTOR AGONIST;
CANNABINOID RECEPTOR ANTAGONIST;
CYCLIC AMP;
CYCLIC GMP;
DOPAMINE;
ISONIAZID;
RADIOLIGAND;
RIMONABANT;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
BEHAVIOR;
BINDING AFFINITY;
BRAIN;
BRAIN MEMBRANE;
CEREBELLUM;
CHO CELL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG ANTAGONISM;
DRUG POTENCY;
DRUG SELECTIVITY;
ENZYME ACTIVITY;
FEMALE;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MOUSE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
RAT;
SMOOTH MUSCLE CONTRACTILITY;
SPLEEN;
VAS DEFERENS;
ANIMAL;
BRAIN;
CANNABINOIDS;
CHO CELLS;
HAMSTERS;
IN VITRO;
MALE;
MICE;
MORPHOLINES;
NAPHTHALENES;
PIPERIDINES;
PYRAZOLES;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, DRUG;
ANIMALIA;
|
|
EID: 0029034879
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/0024-3205(95)00174-5 Document Type: Article |
|
Times cited : (299)
|
|
References (18)
|
